bf/NASDAQ:FOLD_icon.jpeg

COM:AMICUSRX

Amicus Therapeutics

  • Stock

Last Close

9.59

21/11 21:00

Market Cap

3.06B

Beta: -

Volume Today

1.57M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
363K
-
1.22M
237.19%
4.96M
-
36.93M
644.86%
91.25M
147.08%
182.24M
99.72%
260.89M
43.16%
305.51M
17.11%
329.23M
7.76%
399.36M
21.30%
cost of revenue
833K
-
6.24M
648.62%
14.40M
130.98%
21.96M
52.48%
31.04M
41.35%
34.47M
11.02%
38.60M
11.99%
45.20M
17.10%
gross profit
363K
-
1.22M
237.19%
4.13M
-
30.69M
644.10%
76.84M
150.35%
160.27M
108.58%
229.84M
43.41%
271.05M
17.93%
290.63M
7.23%
354.16M
21.86%
selling and marketing expenses
general and administrative expenses
18.89M
-
20.72M
9.65%
47.27M
128.17%
71.15M
50.52%
127.20M
-
selling general and administrative expenses
18.89M
-
20.72M
9.65%
47.27M
128.17%
71.15M
50.52%
88.67M
24.62%
127.20M
43.45%
169.86M
33.54%
156.41M
7.92%
192.71M
23.21%
213.04M
10.55%
275.27M
29.21%
research and development expenses
41.94M
-
47.62M
13.54%
76.94M
61.56%
104.79M
36.20%
149.31M
42.48%
270.90M
81.44%
286.38M
5.71%
308.44M
7.70%
272.05M
11.80%
276.68M
1.70%
152.38M
44.92%
other expenses
1.72M
-
-77K
104.48%
-80K
3.90%
-4.79M
5,891.25%
6.01M
225.35%
-5.63M
193.74%
4.78M
184.78%
8.85M
85.26%
6.21M
29.81%
5.34M
13.96%
-15.89M
397.38%
cost and expenses
62.56M
-
69.89M
11.72%
126.05M
80.35%
180.02M
42.82%
247.81M
37.66%
416.72M
68.16%
482.98M
15.90%
504.74M
4.51%
505.43M
0.14%
533.66M
5.58%
472.85M
11.39%
operating expenses
62.56M
-
69.89M
11.72%
126.05M
80.35%
179.19M
42.16%
241.57M
34.82%
402.32M
66.54%
461.01M
14.59%
473.70M
2.75%
470.97M
0.58%
495.06M
5.12%
427.65M
13.62%
interest expense
46K
-
1.48M
3,126.09%
1.58M
6.33%
5.40M
242.08%
17.24M
219.38%
22.40M
29.94%
18.87M
15.76%
22.43M
18.83%
32.47M
44.80%
37.12M
14.31%
50.15M
35.10%
ebitda
-60.30M
-
-66.97M
11.06%
-123.36M
84.20%
-175.01M
41.87%
-197.18M
12.67%
-316.43M
60.48%
-328.97M
3.96%
-232.56M
29.30%
-196.10M
15.68%
-191.88M
2.15%
-65.62M
65.80%
operating income
-64.18M
-
-68.70M
7.04%
-130.44M
89.86%
-181.89M
39.45%
-441.99M
143.00%
-328.78M
25.61%
-300.74M
8.53%
-243.85M
18.92%
-199.92M
18.02%
-204.43M
2.25%
-73.49M
64.05%
depreciation and amortization
1.72M
-
1.55M
10.01%
1.83M
18.49%
3.24M
76.87%
3.59M
10.83%
4.22M
17.34%
-28.23M
769.50%
11.29M
140.00%
3.82M
66.19%
12.54M
228.58%
7.87M
37.23%
total other income expenses net
-1.08M
-
-114K
89.44%
-5.42M
4,657.89%
-24.92M
359.51%
-225.10M
803.13%
-11.67M
94.82%
-55.17M
372.71%
-30.40M
44.90%
-41.63M
36.95%
-37.61M
9.66%
-76.61M
103.67%
income before tax
-63.15M
-
-70.04M
10.92%
-132.12M
88.63%
-203.78M
54.24%
-449.12M
120.39%
-349.09M
22.27%
-355.91M
1.95%
-274.25M
22.94%
-241.55M
11.92%
-242.04M
0.20%
-150.10M
37.98%
income tax expense
-3.51M
-
-1.11M
68.31%
1.50M
234.59%
-3.74M
349.60%
-165.12M
4,316.13%
-94K
99.94%
478K
608.51%
2.60M
443.51%
8.91M
242.80%
-5.47M
161.43%
1.48M
127.11%
net income
-59.63M
-
-68.93M
15.58%
-132.12M
91.68%
-200.04M
51.41%
-284.00M
41.97%
-349.00M
22.88%
-356.39M
2.12%
-276.85M
22.32%
-250.46M
9.53%
-236.57M
5.55%
-151.58M
35.92%
weighted average shs out
51.29M
-
74.44M
45.15%
109.92M
47.66%
134.40M
22.27%
153.36M
14.10%
185.79M
21.15%
240.42M
29.40%
258.87M
7.67%
271.42M
4.85%
289.06M
6.50%
295.16M
2.11%
weighted average shs out dil
51.29M
-
74.44M
45.15%
109.92M
47.66%
134.40M
22.27%
153.36M
14.10%
185.79M
21.15%
240.42M
29.40%
258.87M
7.67%
271.42M
4.85%
289.06M
6.50%
295.16M
2.11%
eps
-1.16
-
-0.93
19.83%
-1.20
29.03%
-1.49
24.17%
-1.85
24.16%
-1.88
1.62%
-1.48
21.28%
-1.07
27.70%
-0.92
14.02%
-0.82
10.87%
-0.51
37.80%
epsdiluted
-1.16
-
-0.93
19.83%
-1.20
29.03%
-1.49
24.17%
-1.85
24.16%
-1.88
1.62%
-1.48
21.28%
-1.07
27.70%
-0.92
14.02%
-0.82
10.87%
-0.51
37.80%

All numbers in (except ratios and percentages)